Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-05

Clinical Trial Update: 2 Dose Neuraxial Morphine for Prevention of PDPH [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether two doses of neuraxial morphine can prevent postdural puncture headache. The study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neuraxial Morphine (morphine)

Snippet

Sponsor: Columbia University | Conditions: Postdural Puncture Headache | Phase 4 | Status: COMPLETED | Results posted: 2025-02-05